These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37007760)

  • 1. Effects of Aramchol in patients with nonalcoholic fatty liver disease (NAFLD). A systematic review and meta-analysis.
    Malik A; Nadeem M; Amjad W; Malik MI; Javaid S; Farooq U; Naseem K; Khan A
    Prz Gastroenterol; 2023; 18(1):67-75. PubMed ID: 37007760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.
    Malik A; Malik M; Qureshi S
    Can Liver J; 2024 Feb; 7(1):40-53. PubMed ID: 38505782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of elafibranor in patients with liver abnormalities especially non-alcoholic steatohepatitis: a systematic review and meta-analysis.
    Malik A; Nadeem M; Malik MI
    Clin J Gastroenterol; 2021 Dec; 14(6):1579-1586. PubMed ID: 34370218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
    Front Immunol; 2022; 13():949746. PubMed ID: 36159792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fatty acid-bile acid conjugate Aramchol reduces liver fat content in patients with nonalcoholic fatty liver disease.
    Safadi R; Konikoff FM; Mahamid M; Zelber-Sagi S; Halpern M; Gilat T; Oren R;
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2085-91.e1. PubMed ID: 24815326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Wang LL; Zhang PH; Yan HH
    Front Nutr; 2023; 10():1014010. PubMed ID: 36866059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.
    Goodarzi R; Sabzian K; Shishehbor F; Mansoori A
    Phytother Res; 2019 Mar; 33(3):561-570. PubMed ID: 30653773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dapagliflozin in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Sun L; Deng C; Gu Y; He Y; Yang L; Shi J
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101876. PubMed ID: 35321843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Jalali M; Mahmoodi M; Mosallanezhad Z; Jalali R; Imanieh MH; Moosavian SP
    Complement Ther Med; 2020 Jan; 48():102283. PubMed ID: 31987259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI Assessment of Treatment Response in HIV-associated NAFLD: A Randomized Trial of a Stearoyl-Coenzyme-A-Desaturase-1 Inhibitor (ARRIVE Trial).
    Ajmera VH; Cachay E; Ramers C; Vodkin I; Bassirian S; Singh S; Mangla N; Bettencourt R; Aldous JL; Park D; Lee D; Blanchard J; Mamidipalli A; Boehringer A; Aslam S; Leinhard OD; Richards L; Sirlin C; Loomba R
    Hepatology; 2019 Nov; 70(5):1531-1545. PubMed ID: 31013363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Empagliflozin on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Zhang Y; Liu X; Zhang H; Wang X
    Front Endocrinol (Lausanne); 2022; 13():836455. PubMed ID: 35282455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Metformin on Aminotransferase Levels, Metabolic Parameters and Body Mass Index in Nonalcoholic Fatty Liver Disease Patients: A Metaanalysis.
    Hu H; Wang J; Li X; Shen L; Shi D; Meng J
    Curr Pharm Des; 2021; 27(29):3235-3243. PubMed ID: 33719959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of Huazhi Rougan granule in the treatment of non-alcoholic fatty liver: a systematic review and meta-analysis.
    Wang T; Song J; Hu J; Feng S; Zhang H; Wang H; Li B
    Ann Palliat Med; 2021 Dec; 10(12):12969-12984. PubMed ID: 33691456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the Mediterranean Diet Have Any Effect on Lipid Profile, Central Obesity and Liver Enzymes in Non-Alcoholic Fatty Liver Disease (NAFLD) Subjects? A Systematic Review and Meta-Analysis of Randomized Control Trials.
    Del Bo' C; Perna S; Allehdan S; Rafique A; Saad S; AlGhareeb F; Rondanelli M; Tayyem RF; Marino M; Martini D; Riso P
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Nigella sativa in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Tang G; Zhang L; Tao J; Wei Z
    Phytother Res; 2021 Aug; 35(8):4183-4193. PubMed ID: 33728708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of Dachaihu decoction in the treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Mou Z; Gong T; Wu Y; Liu J; Yu J; Mao L
    Front Med (Lausanne); 2024; 11():1397900. PubMed ID: 39015790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
    Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.
    Ma YY; Li L; Yu CH; Shen Z; Chen LH; Li YM
    World J Gastroenterol; 2013 Oct; 19(40):6911-8. PubMed ID: 24187469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of exercise training processes in improving nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Yu X; Wang Y; Lai J; Song T; Duan J
    Ir J Med Sci; 2023 Feb; 192(1):131-142. PubMed ID: 35366201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial.
    El Amrousy D; Abdelhai D; Shawky D
    Eur J Pediatr; 2022 Feb; 181(2):579-586. PubMed ID: 34459959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.